These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

542 related items for PubMed ID: 20093826

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Is regional citrate superior to systemic heparin anticoagulation for continuous renal replacement therapy? A prospective observational study in an adult regional critical care system.
    Bagshaw SM, Laupland KB, Boiteau PJ, Godinez-Luna T.
    J Crit Care; 2005 Jun; 20(2):155-61. PubMed ID: 16139156
    [Abstract] [Full Text] [Related]

  • 3. Continuous renal replacement therapies: anticoagulation in the critically ill at high risk of bleeding.
    Morabito S, Guzzo I, Solazzo A, Muzi L, Luciani R, Pierucci A.
    J Nephrol; 2003 Jun; 16(4):566-71. PubMed ID: 14696760
    [Abstract] [Full Text] [Related]

  • 4. Heparin versus citrate for anticoagulation in critically ill patients treated with continuous renal replacement therapy.
    Tillman J.
    Nurs Crit Care; 2009 Jun; 14(4):191-9. PubMed ID: 19531037
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Citrate versus unfractionated heparin for anticoagulation in continuous renal replacement therapy.
    Liao YJ, Zhang L, Zeng XX, Fu P.
    Chin Med J (Engl); 2013 Apr; 126(7):1344-9. PubMed ID: 23557569
    [Abstract] [Full Text] [Related]

  • 7. Multi-centre evaluation of anticoagulation in patients receiving continuous renal replacement therapy (CRRT).
    Brophy PD, Somers MJ, Baum MA, Symons JM, McAfee N, Fortenberry JD, Rogers K, Barnett J, Blowey D, Baker C, Bunchman TE, Goldstein SL.
    Nephrol Dial Transplant; 2005 Jul; 20(7):1416-21. PubMed ID: 15855212
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Regional citrate anticoagulation for PrismaFlex continuous renal replacement therapy.
    Burry LD, Tung DD, Hallett D, Bailie T, Carvalhana V, Lee D, Ramganesh S, Richardson R, Mehta S, Lapinsky SE.
    Ann Pharmacother; 2009 Sep; 43(9):1419-25. PubMed ID: 19690224
    [Abstract] [Full Text] [Related]

  • 11. A regional citrate anticoagulation protocol for pre-dilutional CVVHDf: the 'Modified Alabama Protocol'.
    Davies H, Morgan D, Leslie G.
    Aust Crit Care; 2008 Aug; 21(3):154-65. PubMed ID: 18635373
    [Abstract] [Full Text] [Related]

  • 12. Citrate anticoagulation during continuous renal replacement therapy in pediatric critical care.
    Davis TK, Neumayr T, Geile K, Doctor A, Hmeil P.
    Pediatr Crit Care Med; 2014 Jun; 15(5):471-85. PubMed ID: 24777299
    [Abstract] [Full Text] [Related]

  • 13. Regional citrate versus heparin anticoagulation for continuous renal replacement therapy in critically ill patients: a meta-analysis with trial sequential analysis of randomized controlled trials.
    Liu C, Mao Z, Kang H, Hu J, Zhou F.
    Crit Care; 2016 May 13; 20(1):144. PubMed ID: 27176622
    [Abstract] [Full Text] [Related]

  • 14. [Continuous renal replacement therapies (CRRT) will remain the most widely adopted dialysis modality in the critically ill].
    Morabito S, Pistolesi V, Cibelli L, Pierucci A.
    G Ital Nefrol; 2009 May 13; 26(1):13-21. PubMed ID: 19255959
    [Abstract] [Full Text] [Related]

  • 15. Regional citrate anticoagulation in patients with liver failure supported by a molecular adsorbent recirculating system.
    Faybik P, Hetz H, Mitterer G, Krenn CG, Schiefer J, Funk GC, Bacher A.
    Crit Care Med; 2011 Feb 13; 39(2):273-9. PubMed ID: 20975551
    [Abstract] [Full Text] [Related]

  • 16. Regional citrate anticoagulation for continuous renal replacement therapy in children.
    Rico MP, Fernández Sarmiento J, Rojas Velasquez AM, González Chaparro LS, Gastelbondo Amaya R, Mulett Hoyos H, Tibaduiza D, Quintero Gómez AM.
    Pediatr Nephrol; 2017 Apr 13; 32(4):703-711. PubMed ID: 27896442
    [Abstract] [Full Text] [Related]

  • 17. [Citrate: an additional resource for anticoagulation in continuous replacement therapy].
    Pozzato M.
    G Ital Nefrol; 2012 Apr 13; 29(1):20-6. PubMed ID: 22388902
    [Abstract] [Full Text] [Related]

  • 18. Citrate clearance in children receiving continuous venovenous renal replacement therapy.
    Chadha V, Garg U, Warady BA, Alon US.
    Pediatr Nephrol; 2002 Oct 13; 17(10):819-24. PubMed ID: 12376810
    [Abstract] [Full Text] [Related]

  • 19. Regional citrate anticoagulation for high volume continuous venovenous hemodialysis in surgical patients with high bleeding risk.
    Kalb R, Kram R, Morgera S, Slowinski T, Kindgen-Milles D.
    Ther Apher Dial; 2013 Apr 13; 17(2):202-12. PubMed ID: 23551677
    [Abstract] [Full Text] [Related]

  • 20. Regional citrate versus heparin anticoagulation for continuous renal replacement therapy: a meta-analysis of randomized controlled trials.
    Wu MY, Hsu YH, Bai CH, Lin YF, Wu CH, Tam KW.
    Am J Kidney Dis; 2012 Jun 13; 59(6):810-8. PubMed ID: 22226564
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.